Published • loading... • Updated
Kelyniam Global Announces Strong Q1 2026 Financial Results
- Kelyniam Global reported its financial results for the first quarter ended March 31, 2026.
- The company showed strong revenue growth and improved profitability in Q1 2026.
- Sales of CustomizedBone™ implants increased by more than 50% compared to the previous year, according to CEO Ross Bjella.
- Total revenue rose 84% to $1,150,130, and income from operations improved to $295,295 from a loss of $.
Insights by Ground AI
39 Articles
39 Articles
keenesentinel.com+38 Reposted by 38 other sources
Kelyniam Global Announces Strong Q1 2026 Financial Results
CANTON, Conn., May 11, 2026 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a leader in custom cranial implants, today reported its financial results for the first quarter ended March 31, 2026. The company delivered excellent performance, with strong revenue growth and…
Coverage Details
Total News Sources39
Leaning Left4Leaning Right4Center14Last UpdatedBias Distribution64% Center
Bias Distribution
- 64% of the sources are Center
64% Center
L 18%
C 64%
R 18%
Factuality
To view factuality data please Upgrade to Premium
